Stoke Therapeutics Appoints Bo Cumbo to its Board of Directors, Enhancing Commercial Expertise as the Company Advances Zorevunersen Development Toward Potential FDA Approval and Commercialization
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 241.21 -1.89 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $243.10 | 52 Week High | $333.65 | |||
| Open | $242.02 | 52 Week Low | $223.02 | |||
| Day High | $243.32 | P/E | 30.88 | |||
| Day Low | $240.13 | EPS | $7.81 | |||
| Volume | 454,427 | |||||
| (NASDAQ: STOK) | Delayed: 25.62 -0.99 (3.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.61 | 52 Week High | $ | |||
| Open | $26.83 | 52 Week Low | $ | |||
| Day High | $27.22 | P/E | N/A | |||
| Day Low | $25.31 | EPS | $ | |||
| Volume | 1,274,365 | |||||
